top of page


The Northwestern Cancer Prevention Consortium has been conducting research and publishing their findings since 2003. Check out the links below to view some of our recently published research articles.


A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: Evaluation of dermal safety, intra-mammary drug distribution, and biologic effects.

Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ , A Randomized Clinical Trial 

Phase Ib Trial of Inhaled Iloprost for The Prevention of Lung Cancer with Predictive and Response Biomarker Assessment

Metformin for Chemoprevention of Lung Cancer in High-Risk Overweight or Obese Individuals

PD15-12 A Pre-surgical Window Trial of Oral Tamoxifen Versus Transdermal 4-Hydroxytamoxifen Gel in Women with Estrogen Receptor Positive Duct Carcinoma In Situ (DCIS)


Surgical Window-of-Opportunity Study of Megestrol Acetate Compared with Megestrol Acetate and Metformin for Endometrial Intraepithelial Neoplasia

Lessons Learned from The Impact of COVID-19 on NCI-Sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-Centric Study Designs

A Randomized, Double-Blinded, Placebo-Controlled Trial of Simvastatin to Prevent Recurrent Pancreatitis

Local Transdermal Delivery of Telapristone Acetate Through Breast Skin, Compared to Oral treatment: A Randomized Double-Blind, Placebo-Controlled Phase II trial

A Phase I Trial of Berberine in Chinese with Ulcerative Colitis

Phase I Trial of Endoxifen Gel Versus Placebo Gel in Women Undergoing Breast Surgery

Scherr CL, Badal HJ, Xu Y, Benante K, Diamond E, Heckman-Stoddard B, & Khan SA. A Pilot Test of The Impact of An Informational Animated Video on Potential Participation in a Window of Opportunity Study. Annual Meeting and Scientific Sessions of the Society of Behavioral Medicine, March 2019

A Phase IIB Pre-surgical Trial of Oral Tamoxifen (TAM) Versus Transdermal 4-Hydroxytamoxifen (4-OHT) in Women with DCIS of The Breast

Progesterone Receptor (PR) Antagonism by Telapristone Acetate (TPA): A Randomized, Placebo-Controlled Phase IIB Pre-Surgical Window Trial in Women with Stage 0-II Breast Cancer

Local Transdermal Therapy (LTT): Drug Permeation and Distribution of Telapristone Acetate (TPA) in a Pre-Surgical Window Study of Women Undergoing Mastectomy

Evaluating Intermittent Dosing of Aspirin for Colorectal Cancer Prevention 

Prevention of Colonic Neoplasia with Polyethylene Glycol: A Short Term Placebo-Controlled Double-Blinded Trial

Myo-Inositol Reduces β-Catenin Activation in Colitis

Selenomethionine and Methyl Selenocysteine: Multiple-Dose Pharmacokinetics in Selenium-Replete Men

Spectral Biomarkers for Chemoprevention of Colonic Neoplasia: a Placebo-Controlled Double-Blinded Trial with Aspirin

Novel Routes for Administering Chemoprevention: Local Transdermal Therapy to The Breasts

Clinical Trial Laboratory Data Nested With in Subject: Components of Variance, Sample Size and Cost


A Randomized Phase II Presurgical Trial of Transdermal 4-Hydroxytamoxifen Gel Versus Oral Tamoxifen in Women with Ductal Carcinoma in Situ of The Breast

A Phase I Trial of Aminolevulinic Acid-Photodynamic Therapy for Treatment of Oral Leukoplakia

Innovative Approaches to Tamoxifen Administration for Breast Cancer Prevention. In: Tamoxifen Concepts and Cancer New Paradigms, Chap 5

A Fitting Prescription for All: Whole Soyfoods as Part of a Varied Plant-Based Diet

Recruitment Strategy Cost and Impact on Minority Accrual to a Breast Cancer Prevention Trial

Soy Isoflavone Supplementation for Breast Cancer Risk Reduction: a Randomized Phase II Trial

Prediction of Menopausal Status from Estrogen-Related Gene Expression in Benign Breast Tissue

Methyl Selenocysteine: Single-Dose Pharmacokinetics in Men

The Ninth Annual American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research ​

Inhibition of Cancer Cell Invasion and Metastasis by Genistein

bottom of page